Compounds > 2,5-bis(1-aziridinyl)-3,6-bis(2-methoxyethoxy)-4-benzoquinone
Page last updated: 2024-08-24

2,5-bis(1-aziridinyl)-3,6-bis(2-methoxyethoxy)-4-benzoquinone and Leukemia, Lymphoid

2,5-bis(1-aziridinyl)-3,6-bis(2-methoxyethoxy)-4-benzoquinone has been researched along with Leukemia, Lymphoid in 1 studies

Research

Studies (1)

TimeframeStudies, this research(%)All Research%
pre-19901 (100.00)18.7374
1990's0 (0.00)18.2507
2000's0 (0.00)29.6817
2010's0 (0.00)24.3611
2020's0 (0.00)2.80

Authors

AuthorsStudies
Holcenberg, JS; Kamen, BA; Siegel, SE1

Other Studies

1 other study(ies) available for 2,5-bis(1-aziridinyl)-3,6-bis(2-methoxyethoxy)-4-benzoquinone and Leukemia, Lymphoid

ArticleYear
Aziridinylbenzoquinone (AZQ) treatment of central nervous system leukemia.
    Cancer treatment reports, 1982, Volume: 66, Issue:12

    Topics: Aziridines; Azirines; Benzoquinones; Central Nervous System Diseases; Child, Preschool; Cyclohexenes; Female; Humans; Leukemia, Lymphoid; Male

1982